Observational Study on Efficacy of Alvesco(Ciclesonide) in Asthma Children and Adolescent in Real Practice

NCT01438255 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 274

Last updated 2012-08-23

No results posted yet for this study

Summary

This is a prospective, non-comparative, open, observational study.

Conditions

Sponsors & Collaborators

  • Handok Inc.

    lead INDUSTRY

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2012-07-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01438255 on ClinicalTrials.gov